KALA
Price
$0.39
Change
-$0.03 (-7.14%)
Updated
Oct 2, 11:06 AM (EDT)
Capitalization
8.71M
Intraday BUY SELL Signals
MLTX
Price
$11.44
Change
-$0.03 (-0.26%)
Updated
Oct 2, 11:06 AM (EDT)
Capitalization
983.83M
46 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

KALA vs MLTX

KALA vs MLTX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
KALA vs. MLTX commentary
Oct 02, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KALA is a Hold and MLTX is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
KALA vs MLTX: Fundamental Ratings
KALA
MLTX
OUTLOOK RATING
1..100
5664
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
24
Undervalued
PROFIT vs RISK RATING
1..100
10097
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
9764
P/E GROWTH RATING
1..100
97100
SEASONALITY SCORE
1..100
n/a38

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MLTX's Valuation (24) in the null industry is somewhat better than the same rating for KALA (64) in the Pharmaceuticals Major industry. This means that MLTX’s stock grew somewhat faster than KALA’s over the last 12 months.

MLTX's Profit vs Risk Rating (97) in the null industry is in the same range as KALA (100) in the Pharmaceuticals Major industry. This means that MLTX’s stock grew similarly to KALA’s over the last 12 months.

MLTX's SMR Rating (98) in the null industry is in the same range as KALA (100) in the Pharmaceuticals Major industry. This means that MLTX’s stock grew similarly to KALA’s over the last 12 months.

MLTX's Price Growth Rating (64) in the null industry is somewhat better than the same rating for KALA (97) in the Pharmaceuticals Major industry. This means that MLTX’s stock grew somewhat faster than KALA’s over the last 12 months.

KALA's P/E Growth Rating (97) in the Pharmaceuticals Major industry is in the same range as MLTX (100) in the null industry. This means that KALA’s stock grew similarly to MLTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KALAMLTX
RSI
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
77%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
MACD
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
77%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
72%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
72%
Advances
ODDS (%)
Bullish Trend 11 days ago
80%
Bullish Trend 11 days ago
84%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 4 days ago
78%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
86%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
80%
COMPARISON
Comparison
Oct 02, 2026
Stock price -- (KALA: $0.42 vs. MLTX: $11.47)
Brand notoriety: KALA and MLTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KALA: 265% vs. MLTX: 92%
Market capitalization -- KALA: $8.71M vs. MLTX: $983.83M
KALA [@Biotechnology] is valued at $8.71M. MLTX’s [@Biotechnology] market capitalization is $983.83M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KALA’s FA Score shows that 0 FA rating(s) are green while MLTX’s FA Score has 1 green FA rating(s).

  • KALA’s FA Score: 0 green, 5 red.
  • MLTX’s FA Score: 1 green, 4 red.
According to our system of comparison, MLTX is a better buy in the long-term than KALA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KALA’s TA Score shows that 5 TA indicator(s) are bullish while MLTX’s TA Score has 5 bullish TA indicator(s).

  • KALA’s TA Score: 5 bullish, 3 bearish.
  • MLTX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both KALA and MLTX are a good buy in the short-term.

Price Growth

KALA (@Biotechnology) experienced а -25.11% price change this week, while MLTX (@Biotechnology) price change was -5.36% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.58%. For the same industry, the average monthly price growth was -14.40%, and the average quarterly price growth was -1.79%.

Reported Earning Dates

MLTX is expected to report earnings on Nov 17, 2026.

Industries' Descriptions

@Biotechnology (-3.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
KALA
Daily Signal:
Gain/Loss:
MLTX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DDC0.210.01
+5.41%
DDC Enterprise Limited
CHEC10.290.02
+0.19%
Chenghe Acquisition III Co
RJET17.99-0.07
-0.39%
Republic Airways Holdings Inc.
WDS21.80-0.37
-1.67%
Woodside Energy Group Limited
LIVN74.70-1.80
-2.35%
LivaNova PLC

KALA and

Correlation & Price change

A.I.dvisor indicates that over the last year, KALA has been closely correlated with MLTX. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if KALA jumps, then MLTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KALA
1D Price
Change %
KALA100%
-2.31%
MLTX - KALA
82%
Closely correlated
-1.97%
AUPH - KALA
45%
Loosely correlated
-1.51%
LRMR - KALA
38%
Loosely correlated
-4.23%
PALI - KALA
31%
Poorly correlated
+5.93%
OVID - KALA
29%
Poorly correlated
-2.41%
More

MLTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLTX has been closely correlated with KALA. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if MLTX jumps, then KALA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLTX
1D Price
Change %
MLTX100%
-1.97%
KALA - MLTX
82%
Closely correlated
-2.31%
XNCR - MLTX
50%
Loosely correlated
-0.72%
NRIX - MLTX
45%
Loosely correlated
-1.56%
AUPH - MLTX
44%
Loosely correlated
-1.51%
XENE - MLTX
44%
Loosely correlated
+4.68%
More